Navigation Links
BMP Sunstone Signs Letter of Intent to Acquire Shengda Pharmaceutical Co.
Date:7/18/2008

Proposed Acquisition to Strengthen Existing Therapeutic Focus Through

Extending the Good Baby Product Line

PLYMOUTH MEETING, Pa., July 18 /Xinhua-PRNewswire-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP; "BMP Sunstone"; the "Company") today announced that its wholly-owned subsidiary, Sunstone (Tangshan) Pharmaceutical Co., Ltd. ("Sunstone") has signed a non-binding letter of intent to acquire 75 percent of Zhangjiakou Shengda Pharmaceutical Co., Ltd ("Shengda"), Zhangjiakou Pharmaceutical Group for up to RMB 30.0 million (approximately $4.4 million). Terms of the acquisition are not yet finalized, as completion is subject to a number of conditions including finalization of due diligence and definitive documentation. The Company intends to use the cash available at Sunstone to fund the acquisition and expects to complete the acquisition by the end of the fourth quarter of 2008. The letter of intent also includes a six month exclusivity clause.

Shengda is a leading manufacturer of pediatric pharmaceuticals, specializing in antibiotic research and development and has approximately 75 product licenses approved by the SFDA in China.

Mr. Zhiqiang Han, President and Chief Operating Officer of BMP Sunstone, stated, "We look forward to the partnership with Shengda. While we are not interested in entering the low-end generic antibiotics market, the Shengda products we intend to acquire specifically target the oral pediatrics market. They fit nicely under our GoodBaby brand and also complement our pediatrics franchise in both the OTC and Rx markets. Utilizing our existing sales coverage and nationally-recognized brand, we intend to realize synergies immediately by increasing sales volume and improving sales margins."

Han continued, "Shengda's main products are amoxicillin tablets, capsules and clavulanate potassium compound preparation. These products include some of the most widely prescribed and effective pediatr
'/>"/>

SOURCE BMP Sunstone Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. BMP Sunstones Propess(R) Recommended as First Line Treatment By the Chinese Medical Association
2. BMP Sunstone to Report First Quarter 2008 Financial Results
3. BMP Sunstone Announces Participation in May Investor Conferences
4. BMP Sunstone Donates RMB 1.2 Million to Earthquake Relief
5. BMP Sunstone Reports First Quarter 2008 Financial Results
6. BMP Sunstone Announces Participation in June Investor Conferences
7. BMP Sunstone Announces Official Launch of Ferriprox in PRC
8. BMP Sunstone Completes Acquisition of Shanghai Rongheng Pharmaceutical Co., Ltd
9. Pot bellies linked to early signs of cardiovascular disease
10. MSU engineering team designs innovative medical device
11. Jump in Youth Suicide Prompts National Childrens Charity KidsPeace to Issue Tips on Prevention, Warning Signs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)... , Brain perfusion applic...nterprise using the Ziostation® thin-client sy...if (PRWEB) January 8, 2009 -- Ziosoft®, Inc. ...software for medical imaging , today announced th...Food and Drug Administration (FDA) for its CT brai...
(Date:1/7/2009)... , By the time pancreatic...has been reported about actor Patrick Swayze) and ...rgical oncologist specializing in pancreatic, live...ed with that reality and has created a groundbreak...pecialists and improve outcomes for patients. ,...
(Date:1/7/2009)... , BEDFORD, Mass., Jan. 7 Insulet Corporation (Na...y with its OmniPod(R) Insulin Management System, t... 27th Annual J.P. Morgan Healthcare Conference. Ma...e Company at 7:30 a.m. PST on January 14, 2009 at ...During the conference presentation, material infor...
(Date:1/7/2009)... , DAYTON, Ohio, Jan. 7 Robbins & Myers, ...nings per share (DEPS) of $0.50 for,its fiscal fir...th $0.40 in,the prior year first quarter. First q... first quarter to $178 million, and orders decreas...acquired product lines and currency,translation, o...
Breaking Medicine News(10 mins):Health News:Ziosoft Receives FDA Clearance for CT Brain Perfusion Application 2Health News:Nationally-Recognized Pancreatic Cancer Surgeon Develops Unique Team Approach to Improve Patient Outcomes 2Health News:Robbins & Myers Announces First Quarter 2009 Results 2Health News:Robbins & Myers Announces First Quarter 2009 Results 3Health News:Robbins & Myers Announces First Quarter 2009 Results 4Health News:Robbins & Myers Announces First Quarter 2009 Results 5Health News:Robbins & Myers Announces First Quarter 2009 Results 6Health News:Robbins & Myers Announces First Quarter 2009 Results 7Health News:Robbins & Myers Announces First Quarter 2009 Results 8Health News:Robbins & Myers Announces First Quarter 2009 Results 9
...of California have developed new technique for reg...in the treatment of spinal cord injuries,// the re...ulation of nerve cells in laboratory rats, which h...he National Academy of Sciences. Nerve cells has...
...ple at high risk for liver injury may be able to r...ase significantly by drinking more than two cups o... people who have liver problem due to heavy alcoho...aving diabetes or iron overload. In the words of t...
...g dissatisfaction amongst physicians regarding the...lly ill patients. This was disclosed in the annual...ssatisfactions focus on pain relief and other end-...cal wards. Furthermore, amongst all categories, Or...
...pressed hope regarding the DNA vaccine trials cond...of the clinical trials have already been completed...es represent the latest innovation in the area of ...njection of one or more genes coding for specific ...
Other Medicine News:Health News:DNA Vaccine Trials Against HIV Virus In Sweden Nurture Hope 2
(Date:12/27/2008).... 27 According to the latest,scie...nsume modest doses of,resveratrol plus an array o...,to 5 glasses of aged, red wine, rather than resv...om.com/cgi-bin/prnh/20080603/LATU039 ) , T...lone fails to prolong,the life of laboratory mice...
(Date:12/17/2008)...he first time that normal stem cells can act as th..., MEMPHIS, Tenn., Dec. 17 /PRNewswire-USNewswire...Hospital have answered a central question in cance... to tumors. Stem cells are immature cells that can...tiated cells that compose the range of body tissue...
(Date:12/17/2008)...wire-FirstCall/ -- Medivation, Inc.,(Nasdaq: MD... enrollment in a,Phase 1-2 dose-escalation clinic...antagonist, in castration-resistant prostate cance...he U.S. Food and Drug Administration (FDA) to,adv... The open-label, U.S. Phase 1-2 study evaluated p...
(Date:12/17/2008)...RNewswire-FirstCall/ -- Neurobiological,Technolog...ed that an independent,Data Safety Monitoring Boa...,trials of Viprinex(TM) for the treatment of acut...s a result, the company has terminated further enr...e the data before evaluating the,potential for an...
Breaking Medicine Technology:Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 3Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 2Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 3Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 3Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 4Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis 2Spanish Health Service Provider Selects Autonomy to Deliver Innovation Within Healthcare 23426 1Spanish Health Service Provider Selects Autonomy to Deliver Innovation Within Healthcare 23426 2Spanish Health Service Provider Selects Autonomy to Deliver Innovation Within Healthcare 23426 3TechCFO Adds Gary Strickland as Partner in Boston Office 6402 1TechCFO Adds Gary Strickland as Partner in Boston Office 6402 2The Center for Professional Innovation and Education 28CfPIE 29 Announces a New Global Regulatory Certification Track 23422 1The Center for Professional Innovation and Education 28CfPIE 29 Announces a New Global Regulatory Certification Track 23422 2The Center for Professional Innovation and Education 28CfPIE 29 Announces a New Global Regulatory Certification Track 23422 3The Center for Professional Innovation and Education 28CfPIE 29 Announces a New Global Regulatory Certification Track 23422 4The Center for Professional Innovation and Education 28CfPIE 29 Announces a New Global Regulatory Certification Track 23422 5The Center for Professional Innovation and Education 28CfPIE 29 Announces a New Global Regulatory Certification Track 23422 6Central Bucks Specialists a Cardiology and Gastroenterology Multi location Clinic Selects MxSecure Inc Provider of Medical Transcription Services 23419 1Central Bucks Specialists a Cardiology and Gastroenterology Multi location Clinic Selects MxSecure Inc Provider of Medical Transcription Services 23419 2Central Bucks Specialists a Cardiology and Gastroenterology Multi location Clinic Selects MxSecure Inc Provider of Medical Transcription Services 23419 3
... - The two most,prevalent forms of genetic mental ...re a common cause, according to researchers at,Sta...a crippled,communication network in the brain, may...etics of the disorders are very different, the,end...aniel Madison,PhD, associate professor of molecul...
...7 - Affymax, Inc.,(Nasdaq:AFFY) today announced th...al of Hematide(TM) dosed monthly in dialysis patie...y Foundation (NKF),2007 Spring Clinical Meeting. T...atients previously treated with,three-times weekly...bin (Hgb) levels can be maintained at clinically a...
Other Medicine Technology:Fragile X, Down Syndromes Linked to Faulty Brain Communication,Stanford Researcher Finds 2Fragile X, Down Syndromes Linked to Faulty Brain Communication,Stanford Researcher Finds 3Fragile X, Down Syndromes Linked to Faulty Brain Communication,Stanford Researcher Finds 4Affymax Announces Results From Phase 2 Clinical Trial of Hematide,for the Treatment of Anemia in Dialysis Patients 2Affymax Announces Results From Phase 2 Clinical Trial of Hematide,for the Treatment of Anemia in Dialysis Patients 3
Wolfs unique apron and vest set distributes weight evenly between shoulders and hips. The vest comes with an attached Thyroid collar - .5mm lead equivalency protection front, 5mm back.
The O.R. Special Protective Apron is now available with an attached Thyroid Collar. The Thyroid Collar is held on with velcro so it adjusts to fully protect the neck. This Apron with Collar is availa
Weve added an elastic belt to help lift the weight off your shoulders and back! The Special Procedure Apron features all around protection to cover you front, side and rear. The over-the-shoulder sna
The O.R. Special Protective Apron is now available with an attached Thyroid Collar. The Thyroid Collar is held on with velcro so it adjusts to fully protect the neck. This Apron with Collar is availa
Medicine Products: